Classical Hodgkin Lymphoma With Reduced 2m/MHC Class I Expression Is Associated With Inferior Outcome Independent of 9p24.1 Status

Cancer immunology research - United States
doi 10.1158/2326-6066.cir-16-0201
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Human Germinal Center-Associated Lymphoma Protein Expression Is Associated With Improved Failure-Free Survival in Brazilian Patients With Classical Hodgkin Lymphoma

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2009English

Reduced PLCG1 Expression Is Associated With Inferior Survival for Myelodysplastic Syndromes

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

HLA Allele E*01:01 Is Associated With a Reduced Risk of EBV-Related Classical Hodgkin Lymphoma Independently of HLA-A*01/*02

PLoS ONE
Multidisciplinary
2015English

Identification of Key Genes and Pathways Associated With Classical Hodgkin Lymphoma by Bioinformatics Analysis

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Differences in Outcome of Patients With Syncytial Variant Hodgkin Lymphoma Compared With Typical Nodular Sclerosis Hodgkin Lymphoma

Therapeutic Advances in Hematology
Hematology
2016English

Hemophagocytic Lymphohistiocytosis in a Patient With Classical Hodgkin Lymphoma

Case Reports in Hematology
2016English

Potentially Inappropriate Medication Use in Elderly Non-Hodgkin Lymphoma Patients Is Associated With Reduced Survival and Increased Toxicities

British Journal of Haematology
Hematology
2017English

Novel Treatment Strategies for Patients With Relapsed Classical Hodgkin Lymphoma

Blood Reviews
OncologyHematology
2010English

Lymphocyte-Rich Classical Hodgkin Lymphoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy